Psychedelics vs Escitalopram for Depressive Symptoms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis
BMJ 2024 Aug 21;386(xx)e078607, TW Hsu, CK Tsai, YC Kao, T Thompson, AF Carvalho, FC Yang, PT Tseng, CW Hsu, CL Yu, YK Tu, CS LiangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.